cambridgebiocapital.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Cambridge Biocapital ⬩ |
| Description | Business, VC deals & science Cambridge Biocapital is the independent weekly newsletter covering business, funding and science news in the world-leading British biotech & VC ecosystem. Be part of the conversation, be in the |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 75.2.70.75 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cambridgebiocapital.com Valuation
|
US$367,918
Last updated: 2023-05-17 11:45:26
cambridgebiocapital.com has Semrush global rank of 28,768,179. cambridgebiocapital.com has an estimated worth of US$ 367,918, based on its estimated Ads revenue. cambridgebiocapital.com receives approximately 42,452 unique visitors each day. Its web server is located in United States, with IP address 75.2.70.75. According to SiteAdvisor, cambridgebiocapital.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$367,918 |
| Daily Ads Revenue | US$340 |
| Monthly Ads Revenue | US$10,189 |
| Yearly Ads Revenue | US$122,262 |
| Daily Unique Visitors | 2,831 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cambridgebiocapital.com. 3600 | A | cambridgebiocapital.com. 3600 | IP: 75.2.70.75 |
| cambridgebiocapital.com. 3600 | A | cambridgebiocapital.com. 3600 | IP: 99.83.190.102 |
| cambridgebiocapital.com. 21600 | NS | cambridgebiocapital.com. 21600 | NS Record: ns-cloud-a1.googledomains.com. |
| cambridgebiocapital.com. 21600 | NS | cambridgebiocapital.com. 21600 | NS Record: ns-cloud-a4.googledomains.com. |
| cambridgebiocapital.com. 21600 | NS | cambridgebiocapital.com. 21600 | NS Record: ns-cloud-a2.googledomains.com. |
| cambridgebiocapital.com. 21600 | NS | cambridgebiocapital.com. 21600 | NS Record: ns-cloud-a3.googledomains.com. |
| cambridgebiocapital.com. 3600 | MX | cambridgebiocapital.com. 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
| cambridgebiocapital.com. 3600 | MX | cambridgebiocapital.com. 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| cambridgebiocapital.com. 3600 | MX | cambridgebiocapital.com. 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| cambridgebiocapital.com. 3600 | MX | cambridgebiocapital.com. 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
| cambridgebiocapital.com. 3600 | MX | cambridgebiocapital.com. 3600 | MX Record: 1 aspmx.l.google.com. |
| cambridgebiocapital.com. 3600 | TXT | cambridgebiocapital.com. 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
| cambridgebiocapital.com. 3600 | TXT | cambridgebiocapital.com. 3600 | TXT Record: google-site-verification=G2VrSVBR942RHZhTaCDPYJmoubemqdvL-uCjxW9TZ6M |
HtmlToTextCheckTime:2023-05-17 11:45:26
| about sponsor subscribe subscribe Thank you! Welcome to Cambridge Biocapital. Oops! Something went wrong while submitting the form. Make sure you submit a valid email. Business, VC deals & science news in the biotech capital of Europe. April 24, 2023 Caristo Therapeutics secures $16.3 million Series A. Maxion Therapeutics awarded £2 million Innovate UK grant. Convatec acquires 30Technology’s antimicrobial platform for £45 million. April 17, 2023 The Good Food Institute raises £12 million. Solasta Bio raises £4 million funding. SynaptixBio secures £13.2 million seed round. April 10, 2023 Biotech VC fund H Tree Capital launches. Pastoral.ai has raised £205,000 pre-seed funding. Syncona-backed Mosaic Therapeutics raises £22.5 million Series A. April 3, 2023 BioCorteX secures $5 million seed funding. SR One raises £489 million biotech fund M:M Bio-backed ThirtyFiveBio emerges raising $20 million seed funding. March 20, 2023 Owlstone Medical and Bicycle Therapeutics enter collaboration. |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: openresty Date: Thu, 24 Mar 2022 08:54:21 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://cambridgebiocapital.com/ HTTP/2 301 server: openresty date: Thu, 24 Mar 2022 08:54:21 GMT content-type: text/html content-length: 166 location: https://www.cambridgebiocapital.com/ HTTP/2 200 server: openresty date: Thu, 24 Mar 2022 08:54:22 GMT content-type: text/html content-length: 18103 x-lambda-id: 45bc5256-de12-4633-9a47-ff01d584d124 fastly-original-body-size: 18103 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 0 x-served-by: cache-iad-kiad7000157-IAD, cache-dub4337-DUB x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1648112062.273870,VS0,VE522 vary: x-wf-forwarded-proto, Accept-Encoding x-cluster-name: eu-west-1-prod-eks-15 |
cambridgebiocapital.com Whois Information
Domain Name: CAMBRIDGEBIOCAPITAL.COM Registry Domain ID: 2568766134_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.google.com Registrar URL: http://domains.google.com Updated Date: 2021-10-29T00:50:42Z Creation Date: 2020-10-28T17:19:55Z Registry Expiry Date: 2022-10-28T17:19:55Z Registrar: Google LLC Registrar IANA ID: 895 Registrar Abuse Contact Email: registrar-abuse@google.com Registrar Abuse Contact Phone: +1.8772376466 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-CLOUD-A1.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A2.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A3.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A4.GOOGLEDOMAINS.COM DNSSEC: signedDelegation DNSSEC DS Data: 4294 8 2 77F21C85B1901192B9276715A7F2646E95452E5FDFE827BA490ADDED8EFFD090 >>> Last update of whois database: 2022-03-24T09:19:23Z <<< |